Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma
NCT00460681
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
220
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Thymopentin
Sponsor
Fudan University